18F-FDG PET/CT作为阴茎癌预后因素的前瞻性研究
该前瞻性研究纳入55例阴茎鳞状细胞癌患者,于治疗前行18F-FDG PET/CT并术后定期随访。原发灶pSUVmax截断值16.6可预测癌症特异性生存,腹股沟淋巴结nSUVmax截断值6.5亦与生存相关,多因素分析证实nSUVmax为淋巴结转移预测因子、pSUVmax可估计生存率。
要点
- pSUVmax截断值16.6可预测阴茎癌癌症特异性生存,p=0.0001。
- nSUVmax截断值6.5可预测癌症特异性生存,p=0.019。
- 多因素分析证实nSUVmax为淋巴结转移预测因子,p=0.043。
核心结论
- 本研究显示18F-FDG PET/CT作为阴茎癌预后工具具有前景,可采用pSUVmax和nSUVmax的特定截断值。
研究设计与样本
- 前瞻性评估2012至2014年诊断为阴茎鳞状细胞癌的55例患者(平均年龄56.6岁),所有受试者治疗前接受18F-FDG PET/CT,术后定期随访。
主要发现
- 53例入选患者中,17例(32.1%)为局限性疾病(cT1-2),24例(45.3%)可触及淋巴结(cN+)。
- 38例(71.7%)行部分阴茎截肢,30例(56.6%)行腹股沟淋巴结清扫术(LND),其中16例(53.3%)病理示肿瘤细胞阳性(pN+)。
- 更具侵袭性疾病患者的18F-FDG肿瘤摄取(pSUVmax)显著更高(p=0.019),腹股沟淋巴结摄取(nSUVmax)能够识别转移性淋巴结(p=0.039)。
- 在cN+患者中,PET/CT对区域淋巴结的准确率为76.2%。
- 随访39个月后,pSUVmax 16.6(p=0.0001)和nSUVmax 6.5(p=0.019)被确定为预测癌症特异性生存的理想值。
关键数值与推荐
- pSUVmax截断值16.6用于预测癌症特异性生存(p=0.0001)。
- nSUVmax截断值6.5用于预测癌症特异性生存(p=0.019)。
- 多因素分析中nSUVmax预测淋巴结转移p=0.043、pSUVmax估计生存率p=0.05。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Penile cancer (PC) is a rare neoplasm with an aggressive behavior and variable prognosis. Lymph node (LN) involvement and pathological features of the primary lesion have been proven to be the most important survival factors. Positron emission tomography/computed tomography with fluorodeoxyglucose labelled with fluorine-18 (18F-FDG PET/CT) provides information on tumor staging and works as a prognostic factor, with promising results in other carcinomas. The aim of the present study is to evaluate PET/CT as a prognostic factor in PC. METHODS: Fifty-five patients (mean age 56.6 y) diagnosed with penile squamous cell carcinoma were prospectively evaluated from 2012 to 2014. All subjects underwent 18F-FDG PET/CT before treatment and were regularly followed after surgery. RESULTS: Out of the 53 patients selected, 17 (32.1%) had localized disease (cT1-2) and 24 (45.3%) had palpable nodes (cN+). Partial penile amputation was performed in 38 patients (71.7%) and inguinal lymphadenectomy (LND) in 30 (56.6%). From the LND group, 16 (53.3%) presented with positive neoplastic cells (pN+). Patients with more aggressive disease had a significantly (p = 0.019) higher 18F-FDG tumor uptake (pSUVmax), while inguinal LN uptake (nSUVmax) was able to recognize metastatic LN (p = 0.039). Some pathological prognostic features, when presented, have shown significant changes in pSUVmax values. Receiver operating characteristic (ROC) curves were performed and specific cutoff values of pSUVmax were evaluated to determine sensitivity and specificity. Regarding regional LNs, PET/CT presented a 76.2% accuracy in cN+ patients. After a 39-month follow up, pSUVmax of 16.6 (p = 0.0001) and nSUVmax of 6.5 (p = 0.019) were established as the ideal values to predict cancer-specific survival. The multivariate analysis confirmed nSUVmax as a predictor for LN metastasis (p = 0.043) and pSUVmax as a mean to estimate survival rate (p = 0.05). CONCLUSION: This study showed promising results on the use of 18F-FDG PET/CT as a prognostic tool for PC, using specific cutoff values of pSUVmax and nSUVmax.
引用
- Salazar A, Júnior EP, Salles PGO, et al. 18F-FDG PET/CT as a prognostic factor in penile cancer. Eur J Nucl Med Mol Imaging. 2018. PMID: 30143840. doi:10.1007/s00259-018-4128-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。